# Multiple Cardiac Sensors for the Management of Heart Failure

Study · id `cardio:ct-nct03237858` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03237858](<https://clinicaltrials.gov/study/NCT03237858>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03237858

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

## Technical summary

Registry record NCT03237858. Randomized; no masking; primary purpose diagnostic. Start 2017-08-30 (actual); primary completion 2020-07-21 (actual). Results posted on 2024-03-27.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 200 participants (enrolled count; ClinicalTrials.gov record NCT03237858, source copy `cardio:ctgov-nct03237858-2024-03-27`, retrieved 2026-10-26)
- Started: 2017-08-30 (actual) (ClinicalTrials.gov record NCT03237858, source copy `cardio:ctgov-nct03237858-2024-03-27`, retrieved 2026-10-26)
- Primary completion: 2020-07-21 (actual) (ClinicalTrials.gov record NCT03237858, source copy `cardio:ctgov-nct03237858-2024-03-27`, retrieved 2026-10-26)
- Completion: 2020-07-21 (actual) (ClinicalTrials.gov record NCT03237858, source copy `cardio:ctgov-nct03237858-2024-03-27`, retrieved 2026-10-26)
- Results first posted: 2024-03-27 (ClinicalTrials.gov record NCT03237858, source copy `cardio:ctgov-nct03237858-2024-03-27`, retrieved 2026-10-26)
- Countries: United States; France; Germany (ClinicalTrials.gov record NCT03237858, source copy `cardio:ctgov-nct03237858-2024-03-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03237858-2024-03-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Multiple Cardiac Sensors for the Management of Heart Failure
- Acronym: MANAGE-HF
- Condition: Heart Failure, Congestive
- Intervention (Device): HeartLogic ON
- Intervention (Device): HeartLogic OFF
- Lead sponsor: Boston Scientific Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Boston Scientific (`cardio:boston-scientific`)

## Provenance

Content hash: 586359a55f3eea4e7d3e3b885196e0cf268eebde9b481c6a565d8114f069fdb9
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
